The tissue damage and anatomical distortion caused by primary prostate cancer treatment are major challenges for surgeons performing salvage surgery.

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

Results from the Phase III EMBARK trial show that in combination with leuprolide, Xtandi (enzalutamide) demonstrated a ...

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

At this time, I suspect your doctor will order some radiology tests, possibly a bone scan to look for the distant spread of ...

PURPOSEUpdate all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer.METHODSThe Expert Panel based recommendations on a ...

American Oncology Institute (AOI) at Citizens Specialty Hospital, Hyderabad, has successfully managed a complex and rare case ...

Prostate cancer recurrence can happen in 20-30% of survivors. It is when the cancer returns after initial treatment, either in the prostate area or elsewhere in the body.

I am sorry, but it is very likely that the cancer has come back somewhere in your body. However, this is not 100 per cent ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

The exercise prescriptions also prevented other new cancers, like breast and prostate cancer. Many included just three to four brisk walks each week.